Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Identify the credit cards that offer rewards without annual fees. Enjoy benefits without the financial strain.
27,064 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
A California jury confronts a high-stakes question: can the way social apps are built cause harm to young users? The ...
If you’re playing the long game, XRP could ride a growing payments ecosystem, regulatory clarity, and broader crypto ...
Anthropic has confidentially filed for an IPO after closing a $65 billion funding round at a near-trillion-dollar val...
Bitcoin steadies near $64k as hawkish Fed rhetoric rattles markets. This guide breaks down what to watch, where a flo...
SK Hynix kicked off trading on Wall Street with a double-digit rally, marking the largest U.S. IPO by a foreign compa...
When a TV showdown becomes a real-world rental, fans race to lock in a stay and lenders notice. This article breaks d...
Investors looking at BBCP can unlock value by decoding the signals behind concrete pumping (bbcp) earnings. This guid...
When a legendary brand names a new leader, investors lean in. Disney's CEO, Josh D'Amaro, arrives with a plan to shar...
A little-known micro-cap trading under $30 is drawing renewed investor interest as quarterly results show improving p...
Franklin Templeton filed for two DRIP-focused ETFs that would redirect dividend payouts from U.S. stocks into Bitcoin...